Deerfield Management Company LP Series C
Legal Name: DEERFIELD MANAGEMENT COMPANY, L.P. SERIES C
Full Contact Details
Deerfield Management Company LP Series C
780 THIRD AVE., 37TH FLOOR, NEW YORK, NY
212-551-1600
212-599-3075
Other Info
Deerfield Management Company LP Series C is legally known as DEERFIELD MANAGEMENT COMPANY, L.P. SERIES C. It is a DE Limited Partnership. This firm has 125 employees, of which 96 are employees in advisory roles. The number of clients served by it is unknown. The firm's last reported SEC (U.S. Securities and Exchange Commission) status is listed as “Approved”, with a registration date of Mar 30, 2012.
Deerfield | Deerfield Management
HOME INVESTMENT INSTITUTE FOUNDATION NEWS AND EVENTS CONTACT US Advancing healthcare® through investment, information and philanthropy. Investment We believe our approaches to capital funding are uniquely flexible to give companies the leverage they need to advance their business goals and set ne…
Direct Owners
-
DAVID JUSTUS CLARK
GENERAL COUNSEL owns less than 5%
-
FLYNN MANAGEMENT LLC
GENERAL PARTNER owns 75% or more
-
JAMES EDWARD FLYNN
PRESIDENT owns less than 5%
-
JONATHAN DAVID ISLER
CHIEF FINANCIAL OFFICER owns less than 5%
-
KAREN ARNONE NOY
CHIEF ADMINISTRATIVE OFFICER owns less than 5%
-
MARIAN LYIA BRANCACCIO
CHIEF COMPLIANCE OFFICER owns less than 5%
Indirect Owners
-
JAMES EDWARD FLYNN
SOLE MEMBER owns 75% or more
Prime Brokers
-
GOLDMAN SACHS & CO. LLC
United States -
MORGAN STANLEY & CO. LLC
United States -
NATIONAL FINANCIAL SERVICES LLC
United States
Firms Located Nearby
Top Holdings
- HORIZON THERAPEUTICS PLC $155,491k
- HORIZON PHARMA INVESTMENT LTD $150,514k
- MYLAN N V $142,121k
- ORCHARD THERAPEUTICS PLC $124,841k
- NEVRO CORP $120,607k
- Homology Medicines $112,730k
- AERIE PHARMACEUTICALS INC $89,625k
- Intersect ENT Inc. $70,761k
- IMMUNOMEDICS INC $69,147k
- Acceleron Pharma Inc $53,617k